Literature DB >> 17158825

Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.

B Daan Westenbrink1, Folkert W Visser, Adriaan A Voors, Tom D J Smilde, Erik Lipsic, Gerjan Navis, Hans L Hillege, Wiek H van Gilst, Dirk J van Veldhuisen.   

Abstract

AIMS: Anaemia is prevalent in the chronic heart failure (CHF) population, but its cause is often unknown. The present study aims to investigate the relation between anaemia, renal perfusion, erythropoietin production, and fluid retention in CHF patients. METHODS AND
RESULTS: We studied 97 patients with CHF, of which 15 had anaemia (Hb<13.0 g/dL in men and Hb<12.0 g/dL in women), without haematinic deficiencies. Glomerular filtration rate (GFR) and extracellular volume (ECV) were measured as the clearance and the distribution volume of constantly infused 125I-iothalamate, respectively. Effective renal plasma flow (ERPF) was determined as the clearance of 131I-hippuran. Anaemic CHF patients displayed significantly reduced GFR (P=0.002), ERPF (P=0.005) and EPO production (P=0.001), and an elevated ECV (P=0.015). Multivariable analysis demonstrated that lower GFR (P=0.003), lower ERPF (P=0.004), lower EPO production (P=0.006), and a higher ECV (P=0.001) were significant independent predictors of lower haemoglobin levels.
CONCLUSION: Anaemia in CHF is not only independently associated with impaired renal perfusion and blunted EPO production, but to fluid retention as well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158825     DOI: 10.1093/eurheartj/ehl419

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  37 in total

Review 1.  The kidney in heart failure: an update.

Authors:  Kevin Damman; Jeffrey M Testani
Journal:  Eur Heart J       Date:  2015-04-02       Impact factor: 29.983

2.  Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients.

Authors:  Lennaert Kleijn; B Daan Westenbrink; Vincent M van Deursen; Kevin Damman; Rudolf A de Boer; Hans L Hillege; Dirk J van Veldhuisen; Adriaan A Voors; Peter van der Meer
Journal:  Clin Res Cardiol       Date:  2014-02-08       Impact factor: 5.460

3.  The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.

Authors:  Dmitry Abramov; Kun-Lun He; Jie Wang; Daniel Burkhoff; Mathew S Maurer
Journal:  J Card Fail       Date:  2011-05-06       Impact factor: 5.712

Review 4.  Impact of systemic venous congestion in heart failure.

Authors:  Matthias Dupont; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2011-12

Review 5.  Anemia and the potential role of erythropoiesis-stimulating agents in heart failure.

Authors:  Haroon A Faraz; Syed F Zafar; Jalal K Ghali
Journal:  Curr Heart Fail Rep       Date:  2008-06

Review 6.  Mechanisms of the cardiorenal syndromes.

Authors:  M Khaled Shamseddin; Patrick S Parfrey
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

7.  Anaemia is an independent predictor of death in patients hospitalized for acute heart failure.

Authors:  Stephan von Haehling; Joerg C Schefold; Lea Majc Hodoscek; Wolfram Doehner; Marwan Mannaa; Stefan D Anker; Mitja Lainscak
Journal:  Clin Res Cardiol       Date:  2010-02       Impact factor: 5.460

Review 8.  Heart failure and anemia: mechanisms and pathophysiology.

Authors:  Inder S Anand
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

Review 9.  Iron and anemia in human biology: a review of mechanisms.

Authors:  Garry J Handelman; Nathan W Levin
Journal:  Heart Fail Rev       Date:  2008-03-25       Impact factor: 4.214

Review 10.  Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.

Authors:  B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.